Synact in Media

December 20, 2022

BioStock: Interview regarding TXP

December 12, 2022

Presentation related to TXP Acquisition and Directed Share Issue

November 4, 2022

BioStock: Interview with CSO Thomas Jonassen

October 10, 2022

BioStock: SynAct submits IND and recruits first patient in phase 2b.

September 20, 2022

SynAct Pharma wins two awards at GHP 2022

July 12, 2022

Listing ceremony Nasdaq Stockholm

June 9, 2022

Presentation at BioStock Life Science Spring Summit

June 1, 2022

Presentation at Life Science Investor Konference, June 1, 2022 – Copenhagen

May 2, 2022

Presentation at Aktiedagen Stockholm May 2, 2022

April 25, 2022

Presentation at Sedermeradagen April 25, 2022

April 6, 2022

BioStock: SynAct Pharma’s CEO on the rights issue and partnering discussions

March 28, 2022

Interview with Direct Studios

March 28, 2022

Presentation regarding the Rights Issue 2022

February 14, 2022

BioStock: SynAct Pharma well positioned for an eventful 2022